Skip to content
ClinCalc Pro
Menu
1st Generation Cephalosporin (Surgical Antibiotic Prophylaxis)

Cefazolin (Surgical Prophylaxis)

Brand names: Kefzol

Cefazolin is a first-generation cephalosporin antibiotic widely used intravenously for surgical antibiotic prophylaxis across many procedures.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It inhibits bacterial cell wall synthesis by binding penicillin-binding proteins, providing reliable activity against staphylococci and streptococci.

Prescribing in practice

  • Give the prophylactic dose within the recommended window before surgical incision to ensure adequate tissue concentrations at the time of incision.
  • Avoid or use with caution in patients with a history of severe penicillin or cephalosporin allergy and check local microbiology policy.
  • Redosing during prolonged procedures or major blood loss may be required per local protocol.

Monitoring

Monitor for hypersensitivity reactions and, with prolonged use, renal function and signs of antibiotic-associated diarrhoea.

Counselling the patient

  • Tell the team about any previous reactions to penicillins or cephalosporins before surgery.
  • Report rash, breathlessness or swelling promptly as these may indicate allergy.
  • Report severe or persistent diarrhoea after antibiotic use.

Evidence & guidelines

Cefazolin is recommended for surgical prophylaxis in many procedures by national guidance including NICE and SIGN.

Reference: WHO SSI Guidelines 2016; SIGN 104 Antibiotic Prophylaxis in Surgery; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.